PepsiCo, Palantir rise; Neogen, Akero Therapeutics fall, Tuesday, 10/10/2023

The beverage and snack giant raised its profit forecast for the year.PepsiCo raises 2023 profit expectations as price hikes offset falling sales volumeThe banking company is reportedly considering selling its insurance brokerage unite to Stone Point.

The data-mining technology company was awarded a new contract with the U.S. Army.The video-gaming software company said CEO John Riccitiello is retiring.Investors were disappointed by the drug developer’s latest update on a potential liver condition treatment.The maker of windows and doors reportedly rejected a buyout offer from Miter Brands.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves premarket: Palantir, PepsiCo, Rivian and moreThese are the stocks posting the largest moves in premarket trading.
Source: NBCNewYork - 🏆 270. / 63 Read more »

Akero Therapeutics shares plunge on liver disease treatment's mixed resultsCompany’s lead product candidate shows some benefit for patients with cirrhosis due to fatty liver disease
Source: MarketWatch - 🏆 3. / 97 Read more »

PepsiCo earnings top forecasts as price increases support profit boostPepsiCo added another round of price increases to its solid organic sales growth, allowing the drinks and snacks giant to lift its full year profit forecast for a third straight quarter.
Source: startelegram - 🏆 248. / 63 Read more »

PepsiCo third-quarter core earnings per share top estimates amid price hikesPepsiCo third-quarter core earnings per share top estimates amid price hikes
Source: Investingcom - 🏆 450. / 53 Read more »